Bausch Health Companies Inc.
BHC
$6.00
$0.2153.72%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 355.17% | -162.37% | 209.41% | -950.00% | 115.63% |
Total Depreciation and Amortization | 0.66% | -0.65% | -4.66% | 1.26% | -0.63% |
Total Amortization of Deferred Charges | 64.86% | 178.72% | -238.24% | 0.00% | 0.00% |
Total Other Non-Cash Items | -3,875.00% | -102.20% | 4,450.00% | 157.14% | 68.18% |
Change in Net Operating Assets | 240.00% | 43.97% | -192.06% | 293.75% | 191.43% |
Cash from Operations | 36.97% | -64.89% | 48.40% | 6.58% | 80.09% |
Capital Expenditure | 13.91% | -8.49% | -49.30% | 8.97% | 4.88% |
Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 400.00% | 0.00% |
Cash Acquisitions | 100.00% | 86.81% | -102.22% | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 66.67% | 0.00% | -133.33% | 550.00% | -125.00% |
Cash from Investing | 23.08% | 35.00% | -96.08% | -29.11% | -8.22% |
Total Debt Issued | 20,644.00% | -90.12% | -- | -100.00% | 6.67% |
Total Debt Repaid | -5,832.74% | 59.12% | -150.61% | 66.87% | -26.92% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 81.25% | -433.33% | 40.00% | -25.00% | 71.43% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -266.67% | -71.43% | 65.00% | -300.00% | 54.55% |
Cash from Financing | 345.21% | -271.76% | 144.97% | 55.42% | -24.71% |
Foreign Exchange rate Adjustments | 85.71% | 160.00% | -369.23% | 244.44% | -80.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1,431.82% | -109.76% | 255.12% | 196.21% | 36.23% |